ClinicalTrials.govpublic full text
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
pancreatic cancer, breast cancer, gastric cancer, non small cell lung cancer, cervical cancer, endocervical cancer, squamous cell carcinoma of head and neck, bladder urothelial cancer, colorectal cancer, esophageal cancer, ovarian cancer, renal cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 833985
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.